The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4298-4305

  D'Alessio, A ^a   Califano, D ^a   Incoronato, M ^b   Santelli, G ^a   Florio, T ^c,d   Schettini, G ^c,d   Carlomagno, M S ^b   Cerchia, L ^e   De Franciscis, V ^e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; ISOENZYME; METHIONINE; MUTANT PROTEIN; PHOSPHATASE; PROTEIN; PROTEIN KINASE B; PROTEIN RET; PROTEIN TYROSINE PHOSPHATASE SHP 2; THREONINE; TRANSFORMING PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CARCINOMA; CONGENITAL MALFORMATION; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; INTRACELLULAR SPACE; NEUROENDOCRINE DISEASE; NONHUMAN; ONCOGENE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTRACELLULAR MEMBRANES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NERVE GROWTH FACTORS; ONCOGENE PROTEINS; PC12 CELLS; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-RET; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0141785493     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0620     Document Type: Article

References (32)

1. Airaksinen MS, Titievsky A, Saarma M 1999 GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13:313-325
2. Airaksinen MS, Saarma M 2002 The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394
3. Saarma M 2000 GDNF - a stranger in the TGF-β superfamily? Eur J Biochem 267:6968-6971
4. Mak YF, Ponder BA 1996 RET oncogene. Curr Opin Genet Dev 6:82-86
5. Ponder BA 1999 The phenotypes associated with Ret mutations in the multiple endocrine neoplasia type 2 syndrome. Cancer Res 59:1736-1741
6. Hansford JR, Mulligan LM 2000 Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817-827
7. Jhiang SM 2000 The RET proto-oncogene in human cancers. Oncogene 19:5590-5597
8. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC 1995 Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373:536-539
9. Besset V, Scott RP, Ibanez CF 2000 Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J Biol Chem 275:39159-39166
10. Qiao S, Iwashita T, Furukawa T, Yamamoto M, Sobue G, Takahashi M 2001 Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. J Biol Chem 276:9460-9467
11. Hennige AM, Lammers R, Hoppner W, Arlt D, Strack V, Teichmann R, Machicao F, Ullrich A, Haring HU, Kellerer M 2001 Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1. Endocrinology 142:4441-4447
12. Lu W, Gong D, Bar-Sagi D, Cole PA 2001 Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 8:759-769
13. Milarski KL, Saltiel AR 1994 Expression of catalitically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 269:21239-21243
14. Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M 1994 Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol 14:6674-6682
15. Tang TL, Freeman Jr R, O'Reilly AM, Neel BG, Sokol SY 1995 The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80:473-483
16. Streuli M 1996 Protein tyrosine phosphatases in signaling. Curr Opin Cell Biol 8:182-188
17. Neel BG Tonks NK 1997 Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 9:193-204
18. Van Vactor D, O'Reilly AM, Neel BG 1998 Genetic analysis of protein tyrosine phosphatases. Curr Opin Genet Dev 8:112-126
19. Florio T, Thellung S, Arena S, Corsaro A, Bajetto A, Schettini G, Stork PJS 2000 Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. J Physiol (Paris) 94:239-250
20. Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI 2001 The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20:6018-6025
21. Hakak Y, Hsu YS, Martin GS 2000 Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 19:3164-3171
22. Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R, Neel BG 2002 Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2. Mol Cell Biol 22:4062-4072
23. Califano D, D'Alessio A, Colucci-D'Amato GL, De Vita G, Monaco C, Santelli G, Di Fiore PP, Vecchio G, Fusco A, Santoro M, de Franciscis V 1996 A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc Natl Acad Sci USA 93:7933-7937
24. Ginty DD, Bonni A, Greenberg ME 1994 Cell 77:713-725.
25. Califano D, Rizzo C, D'Alessio A, Colucci-D'Amato GL, Calì G, Cannada-Bartoli P, Santelli G, Vecchio G, de Franciscis V 2000 Signaling through Ras is essential for Ret oncogene-induced cell differentiation in PC12 cells. J Biol Chem 275:19297-19305
26. Segouffin-Cariou C, Billaud M 2000 Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 275:3568-3576
27. De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M 2000 Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res 60:3727-3731
28. Datta SR, Brunet A, Greenberg ME 1999 Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
29. Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M 2001 Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20:1929-1938
30. Wright JH, Drueckes P, Bartoe J, Zhao Z, Shen SH, Krebs EG 1997 A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation. Mol Biol Cell 8:1575-1585
31. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383
32. Murakami H, Iwashita T, Asai N, Shimono Y, Iwata Y, Kawai K, Takahashi M 1999 Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signaling molecules mediated by ret with the MEN 2B mutation. Biochem Biophys Res Commun 262:68-75